1.
Open Forum Infect Dis
; 8(7): ofab299, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34258322
RESUMO
Immune response after a single dose of BNT162b2 vaccine was markedly increased in subjects with previous severe acute respiratory syndrome coronavirus 2 infection, reaching similar immunoglobulin titers to those elicited by the full 2 doses in naive cases, and increased modestly after the second dose. These data may inform the priority of the boosting dose.